These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


201 related items for PubMed ID: 16247433

  • 1. Protective role of interleukin-10 promoter gene polymorphism in the pathogenesis of invasive pulmonary aspergillosis after allogeneic stem cell transplantation.
    Seo KW, Kim DH, Sohn SK, Lee NY, Chang HH, Kim SW, Jeon SB, Baek JH, Kim JG, Suh JS, Lee KB.
    Bone Marrow Transplant; 2005 Dec; 36(12):1089-95. PubMed ID: 16247433
    [Abstract] [Full Text] [Related]

  • 2. IL-10 promoter gene polymorphism associated with the occurrence of chronic GVHD and its clinical course during systemic immunosuppressive treatment for chronic GVHD after allogeneic peripheral blood stem cell transplantation.
    Kim DH, Lee NY, Sohn SK, Baek JH, Kim JG, Suh JS, Lee KB, Shin IH.
    Transplantation; 2005 Jun 15; 79(11):1615-22. PubMed ID: 15940053
    [Abstract] [Full Text] [Related]

  • 3. IL-6 and IL-10 promoter gene polymorphisms of patients and donors of allogeneic sibling hematopoietic stem cell transplants associate with the risk of acute graft-versus-host disease.
    Karabon L, Wysoczanska B, Bogunia-Kubik K, Suchnicki K, Lange A.
    Hum Immunol; 2005 Jun 15; 66(6):700-10. PubMed ID: 15993715
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Vascular endothelial growth factor gene polymorphisms may predict the risk of acute graft-versus-host disease following allogeneic transplantation: preventive effect of vascular endothelial growth factor gene on acute graft-versus-host disease.
    Kim DH, Lee NY, Lee MH, Sohn SK.
    Biol Blood Marrow Transplant; 2008 Dec 15; 14(12):1408-16. PubMed ID: 19041064
    [Abstract] [Full Text] [Related]

  • 6. Interleukin-10 gene polymorphism in bone marrow transplant recipients.
    Azarpira N, Ramzi M, Aghdaie MH, Darai M, Geramizadeh B.
    Exp Clin Transplant; 2008 Mar 15; 6(1):74-9. PubMed ID: 18405249
    [Abstract] [Full Text] [Related]

  • 7. Risk-factor analysis for predicting progressive- or quiescent-type chronic graft-versus-host disease in a patient cohort with a history of acute graft-versus-host disease after allogeneic stem cell transplantation.
    Sohn SK, Kim DH, Baek JH, Kim JG, Lee KB, Lee KH, Lee JH, Choi SJ, Lee JH, Shin IH.
    Bone Marrow Transplant; 2006 Apr 15; 37(7):699-708. PubMed ID: 16501588
    [Abstract] [Full Text] [Related]

  • 8. Donor methylenetetrahydrofolate reductase genotype is associated with graft-versus-host disease in hematopoietic stem cell transplant patients treated with methotrexate.
    Murphy N, Diviney M, Szer J, Bardy P, Grigg A, Hoyt R, King B, Macgregor L, Holdsworth R, McCluskey J, Tait BD.
    Bone Marrow Transplant; 2006 Apr 15; 37(8):773-9. PubMed ID: 16518429
    [Abstract] [Full Text] [Related]

  • 9. Relation of an interleukin-23 receptor gene polymorphism to graft-versus-host disease after hematopoietic-cell transplantation.
    Elmaagacli AH, Koldehoff M, Landt O, Beelen DW.
    Bone Marrow Transplant; 2008 May 15; 41(9):821-6. PubMed ID: 18209723
    [Abstract] [Full Text] [Related]

  • 10. Genetic variants of IL6 gene promoter influence on C-reactive protein levels but are not associated with susceptibility to invasive pulmonary aspergillosis in haematological patients.
    Sainz J, Pérez E, Gómez-Lopera S, López-Fernández E, Moratalla L, Oyonarte S, Jurado M.
    Cytokine; 2008 Mar 15; 41(3):268-78. PubMed ID: 18191407
    [Abstract] [Full Text] [Related]

  • 11. IL2 and TNFA gene polymorphisms and the risk of graft-versus-host disease after allogeneic haematopoietic stem cell transplantation.
    Viel DO, Tsuneto LT, Sossai CR, Lieber SR, Marques SB, Vigorito AC, Aranha FJ, de Brito Eid KA, Oliveira GB, Miranda EC, de Souza CA, Visentainer JE.
    Scand J Immunol; 2007 Dec 15; 66(6):703-10. PubMed ID: 18021367
    [Abstract] [Full Text] [Related]

  • 12. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL.
    Dan Med Bull; 2007 May 15; 54(2):112-39. PubMed ID: 17521527
    [Abstract] [Full Text] [Related]

  • 13. Contribution of TNF-alpha and IL-10 gene polymorphisms to graft-versus-host disease following allo-hematopoietic stem cell transplantation.
    Takahashi H, Furukawa T, Hashimoto S, Suzuki N, Kuroha T, Yamazaki F, Inano K, Takahashi M, Aizawa Y, Koike T.
    Bone Marrow Transplant; 2000 Dec 15; 26(12):1317-23. PubMed ID: 11223972
    [Abstract] [Full Text] [Related]

  • 14. Role of non-HLA genetic polymorphisms in graft-versus-host disease after haematopoietic stem cell transplantation.
    Bertinetto FE, Dall'Omo AM, Mazzola GA, Rendine S, Berrino M, Bertola L, Magistroni P, Caropreso P, Falda M, Locatelli F, Busca A, Amoroso A.
    Int J Immunogenet; 2006 Oct 15; 33(5):375-84. PubMed ID: 16984283
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Functional polymorphism of CTLA-4 and ICOS genes in allogeneic hematopoietic stem cell transplantation.
    Wu J, Tang JL, Wu SJ, Lio HY, Yang YC.
    Clin Chim Acta; 2009 May 15; 403(1-2):229-33. PubMed ID: 19332044
    [Abstract] [Full Text] [Related]

  • 18. Evidence that donor intrinsic response to G-CSF is the best predictor of acute graft-vs-host disease following allogeneic peripheral blood stem cell transplantation.
    Dhédin N, Chamakhi I, Perreault C, Roy DC, Sauvageau G, Ducruet T, Busque L, Fish D, Bélanger R, Roy J.
    Exp Hematol; 2006 Jan 15; 34(1):107-14. PubMed ID: 16413397
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.